再結合アデノウイルスベクトルベースのエボラワクチンの安全性と免疫性
Martin P Grobusch1, Abraham Goorhuis2
1Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands; Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany; Lion Heart Medical Research Unit, Yele, Sierra Leone.
Lancet (London, England)
|December 27, 2016
まとめ
No abstract available in PubMed .
さらに関連する動画
12:09Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
43.5K
08:14Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
Published on: October 26, 2018
9.0K
